Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008 |
|
Medicine details |
|
Medicine name | zilucoplan (Zilbrysq®) |
Formulation | Solution for injection |
Reference number | 4568 |
Indication | Treatment of generalized myasthenia gravis |
Company | UCB Pharma Ltd |
BNF chapter | Musculoskeletal & joint diseases |
Assessment type | N/A |
Status | Excluded due to NICE appraisal |
Date of issue | 17/03/2023 |
NICE guidance | ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008 |